Showing results (621-630 of 3,591) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|December 17, 2013
Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1C Bernsmeier, D Calabrese, M H Heim, et al.Journal of Viral Hepatitis|December 17, 2013
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trialJ Wiegand, H Wedemeyer, A Franke, et al.Journal of Viral Hepatitis|October 22, 2013
Seronegative hepatitis C virus infection in patients with lymphoproliferative disordersE Kisiel, M Radkowski, A Pawelczyk, et al.Journal of Viral Hepatitis|August 23, 2014
Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010M G Head, J R Fitchett, G S Cooke, et al.Journal of Viral Hepatitis|August 19, 2014
Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patientsD Fuster, A Sanvisens, F Bolao, et al.Journal of Viral Hepatitis|September 5, 2014
Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infectionM J Conroy, R Mac Nicholas, R Grealy, et al.Journal of Viral Hepatitis|September 2, 2014
Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeedingM F Pirillo, P Scarcella, M Andreotti, et al.Journal of Viral Hepatitis|December 20, 2013
Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapyM Lee, S Oh, H J Lee, et al.Journal of Viral Hepatitis|December 18, 2013
Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replicationS J Yu, J-W Kim, J-H Lee, et al.Journal of Viral Hepatitis|December 31, 2013
2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitorM H Cho, H Jeong, Y S Kim, et al.Pageof 360